VISCHER advised Blue Owl in connection with the USD 500 m financing to Madrigal Pharmaceuticals VISCHER advised Blue Owl on all Swiss legal aspects of the financing transaction, including an up to…
VISCHER strengthens its M&A and insurance teams VISCHER AG is delighted to announce the appointment of Dr. iur. Kevin M. Hubacher, J.M. (LL.M.), as a partner, effective October 1, 2025. VISCHER AG is…
As a fiduciary, I am your direct point of contact for all matters relating to finance and accounting. My responsibilities include accurate bookkeeping, preparation of financial statements, payroll…
Proteomedix AG licenses manufacturing IP to Immunovia AB VISCHER advised Proteomedix AG, a Swiss biotech subsidiary of Onconetix, Inc., on a licensing agreement with Immunovia AB, a Swedish…
Best Co-Founders Forever? Anticipating Legal and Tax Considerations for Founders of Swiss Startups (Nr. 4) The entrepreneurial journey is full of surprises, and progressing "according to plan" can…
Medartis acquires remaining 53% of KeriMedical Medartis (SIX: MED), an orthopedic company based in Basel specializing in head and extremity surgery, has acquired the remaining 53% of Geneva-based…
Schivo acquires Mecaplast SA VISCHER advised Schivo on the acquisition of Mecaplast SA. Schivo has acquired Mecaplast SA, a highly specialized Swiss manufacturer of high-precision injection-moulded…
Kevin Hubacher specializes in domestic and cross-border M&A, private equity, venture capital, and insurance transactions (including portfolio transfers and reinsurance arrangements), as well as…
Nikola Atanasijevic completed his Master’s degree in Law at the University of Lucerne in 2025. Prior to that, he obtained a Bachelor of Science in Business Law, which additionally provided him with a…
Nina Bisig completed her Master of Law at the University of Fribourg in 2025. Previously, she obtained a bilingual bachelor's degree (French/German) with an emphasis on European law at the same…
